Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Follicular × Selenium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 10 Urinary Bladder Neoplasms 3 Precancerous Conditions 3 Male Urogenital Diseases 2 Colonic Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Nodule 1 Rectal Neoplasms 1 Polyps 1 Ovarian Neoplasms 1 Non-melanoma Skin Cancer 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Inflammation 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Arsenic Poisoning 1 Adenomatous Polyps 1

Interventions

Rituximab 251 Cyclophosphamide 210 fludarabine phosphate 90 Peripheral Blood Stem Cell Transplantation 90 Filgrastim 80 Etoposide 74 Lenalidomide 71 Radiotherapy 70 Vincristine 69 Prednisone 69 Doxorubicin 56 Bendamustine Hydrochloride 55 Mycophenolic Acid 54 Whole-Body Irradiation 52 Cyclosporine 50 fludarabine 46 Melphalan 45 obinutuzumab 42 Tacrolimus 42 Cytarabine 42 Busulfan 41 Methotrexate 38 Antilymphocyte Serum 34 Methylprednisolone 31 Carmustine 30 Bortezomib 29 ibritumomab tiuxetan 28 sargramostim 27 Dexamethasone 27 ibrutinib 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡